Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
50 participants
OBSERVATIONAL
2020-07-02
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Smartphone App-assisted Short-term Antibiotic Therapy
NCT06126900
Information Systems-enabled Outreach Program for Adverse Drug Events
NCT02059044
Mobile-health Approach to Gather Clinical Information From Patients Following Hospital Discharge
NCT04709939
Acute Admission to Hallingdal Sjukestugu
NCT01069107
Co-Development and Evaluation of a Complex Intervention to Increase Medication Safety in Nursing Homes
NCT04990986
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The pre-project was carried out with a qualitative approach under the auspices of SINTEF 2018/2019.
The main project consists of sub-study 1 and sub-study 2 (2020/2022).
Sub-study 1: The project use an iterative, user-centered service methodology with a qualitative approach. Here, SINTEF has the main responsibility for a qualitative summary after conducting interviews, observations and group discussions with patients, next of kins and health professionals regarding the development and testing / quality assurance of the new concept / service course for home treatment.
Sub-study 2: The approach here is quantitative. Descriptive data must be obtained from the hospital and municipal patient records, patient administration system (PAS) at Kristiansund hospital, alarm data from the Regional Response Center and pump log from the individual patient's infusion pump after home treatment.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients needing antibiotics infusion
Patients needing antibiotics infusion A new model of interaction across health services with use of welfare technology and telemedicine Instead of admitted to the hospital, patients are followed up at home by the municipal regional response center and nurses in the response team according to the individual treatment plan. Hospital physicians are medically responsible throughout the course.
A new model of interaction across health services with use of welfare technology and telemedicine
Instead of admitted to the hospital, patients are followed up at home by the municipal regional response center and nurses in the response team according to the individual treatment plan. Hospital physicians are medically responsible throughout the course.
Next of kin
Next of kin A new model of interaction across health services with use of welfare technology and telemedicine Instead of admitted to the hospital, patients are followed up at home by the municipal regional response center and nurses in the response team according to the individual treatment plan. Hospital physicians are medically responsible throughout the course.
A new model of interaction across health services with use of welfare technology and telemedicine
Instead of admitted to the hospital, patients are followed up at home by the municipal regional response center and nurses in the response team according to the individual treatment plan. Hospital physicians are medically responsible throughout the course.
Health professionals
A new model of interaction across health services with use of welfare technology and telemedicine Instead of admitted to the hospital, patients are followed up at home by the municipal regional response center and nurses in the response team according to the individual treatment plan. Hospital physicians are medically responsible throughout the course.
A new model of interaction across health services with use of welfare technology and telemedicine
Instead of admitted to the hospital, patients are followed up at home by the municipal regional response center and nurses in the response team according to the individual treatment plan. Hospital physicians are medically responsible throughout the course.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
A new model of interaction across health services with use of welfare technology and telemedicine
Instead of admitted to the hospital, patients are followed up at home by the municipal regional response center and nurses in the response team according to the individual treatment plan. Hospital physicians are medically responsible throughout the course.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
A692 Borreliosis G00 - G009 Central nervous system inflammatory disorders I33 Endocarditis J86 Empyema D46.3 Spondylodiscitis M86 Osteomyelitis T84 Prosthesis / osteosynthesis infections M00.0-M00.9 Pyogen / septic arthritis J40-J47 Chronic diseases of the lower respiratory tract
* Competent to give consent
* The infection can not be treated with oral antibiotics in monotherapy
* Selected IV antibiotics must be suitable for administration via selected pumps
* The patient's condition is stable and does not require frequent observation by health care professionals
* The patient is motivated and willing to participate in intravenous treatment in home hospitals
* Must, after training, demonstrate mastery of practical procedures related to pump handling and any other procedures described in the patient's treatment plan
* The home must be suitable for intravenous antibiotic treatment; access to refrigerators, hygienic conditions, social conditions
* The patient must have a mobile phone and be able to handle the system for fast and secure communication with the Regional Response Center (RRO)
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
SINTEF Health Research
OTHER
Kristiansund municipality
UNKNOWN
Centre for Health Innovation
UNKNOWN
Hospital Pharmacy of Central Norway Trust
UNKNOWN
Helse Møre og Romsdal HF
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Torstein Hole, md phd
Role: STUDY_DIRECTOR
Møre og Romsdal Hospital Trust
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Helse Møre og Romsdal HF, Kristiansund sjukehus, Medisinsk Avdeling
Kristiansund, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019/60
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.